• 35375 Citations
  • 101 h-Index
1978 …2023
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1978 2019

2019
Sclerosing Cholangitis
Cholangiocarcinoma
Practice Guidelines
Gallbladder Neoplasms
Neoplasms
1 Citation (Scopus)

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Early Detection of Cancer
Cholangiocarcinoma
Neoplasms
Inflammatory Bowel Diseases
2 Citations (Scopus)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., Feb 14 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Epidemiology
Neoplasms
End Stage Liver Disease
Cholangiocarcinoma

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Registries
Demography
Patient Reported Outcome Measures
Databases

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Pruritus
Fatigue
Fibrosis
1 Citation (Scopus)

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. & LaRusso, N. F., Jan 1 2019, In : Scandinavian Journal of Gastroenterology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Curcumin
Alkaline Phosphatase
Safety
Serum

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
Cholangitis
Fibrosis
Therapeutics
Survival
Patient Advocacy
1 Citation (Scopus)

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

Esophageal and Gastric Varices
Varicose Veins
ROC Curve
Fibrosis
Digestive System Endoscopy
1 Citation (Scopus)

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
4 Citations (Scopus)

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Liver
2018
1 Citation (Scopus)

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

Cholangitis
Antibodies
Autoimmune Hepatitis
Muscles
11 Citations (Scopus)

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. & Tabibian, J. H., Mar 1 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

Liver Diseases
Quality of Life
Pregnancy
Sclerosing Cholangitis
Cholangitis
63 Citations (Scopus)

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

Fatty Liver
Fibrosis
Therapeutics
Non-alcoholic Fatty Liver Disease
Clinical Trials
9 Citations (Scopus)

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Clinical Trials
Gastroenterology
Rare Diseases
Natural History
68 Citations (Scopus)

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

Fibrosis
Elasticity Imaging Techniques
Liver Cirrhosis
Liver
Non-alcoholic Fatty Liver Disease
1 Citation (Scopus)

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

Liver Abscess
Proton Pump Inhibitors
2 Citations (Scopus)

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
Fibric Acids
Cholangitis
Pruritus
Bezafibrate
Ursodeoxycholic Acid

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
Liver Diseases
End Stage Liver Disease
Liver Transplantation
6 Citations (Scopus)

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Cholangitis
Health
Ursodeoxycholic Acid
African Americans
Liver Diseases
5 Citations (Scopus)

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

Cholangitis
Hispanic Americans
Liver Transplantation
Mortality
Transplants
7 Citations (Scopus)

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

Cholangitis
Mortality
Ursodeoxycholic Acid
Incidence
Therapeutics
20 Citations (Scopus)

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Liver
Incidence
Fibrosis

Managing PBC: Expanding the Provider Comfort Zone

Chascsa, D. M. & Lindor, K., Jun 9 2018, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 1 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

Cholangitis
Natural History
Ursodeoxycholic Acid
Paris
Gastroenterology
32 Citations (Scopus)

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, K., Bowlus, C. L., Boyer, J., Levy, C. & Mayo, M., Jan 1 2018, (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

Cholangitis
4 Citations (Scopus)

Primary sclerosing cholangitis, part 1: Epidemiology, etiopathogenesis, clinical features, and treatment

Tabibian, J. H., Ali, A. H. & Lindor, K., May 1 2018, In : Gastroenterology and Hepatology. 14, 5, p. 293-304 12 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Epidemiology
Liver Transplantation
Therapeutics
End Stage Liver Disease
4 Citations (Scopus)

Primary sclerosing cholangitis, part 2: Cancer risk, prevention, and surveillance

Tabibian, J. H., Ali, A. H. & Lindor, K., Jul 1 2018, In : Gastroenterology and Hepatology. 14, 7, p. 427-432 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Neoplasms
Cholangiocarcinoma
Expert Testimony
Gallbladder

Primary sclerosing cholangitis in children versus adults: lessons for the clinic

Adike, A., Carey, E. J. & Lindor, K., Oct 3 2018, In : Expert Review of Gastroenterology and Hepatology. 12, 10, p. 1025-1032 8 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Pediatrics
Liver Diseases
Literature
Inflammatory Bowel Diseases
14 Citations (Scopus)

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

Damman, J. L., Rodriguez, E. A., Ali, A. H., Buness, C. W., Cox, K. L., Carey, E. J. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 886-895 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Vancomycin
Inflammatory Bowel Diseases
Therapeutics
Anti-Bacterial Agents
19 Citations (Scopus)

Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis

Ali, A. H., Tabibian, J. H., Nasser-Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J. & Lindor, K., Jun 1 2018, In : Hepatology. 67, 6, p. 2338-2351 14 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Neoplasms
Gallbladder
Survival
2017
16 Citations (Scopus)

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Gallbladder Neoplasms
Colorectal Neoplasms
Neoplasms
15 Citations (Scopus)

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Fatigue
Randomized Controlled Trials
Placebos
Safety
11 Citations (Scopus)

Curcumin in hepatobiliary disease: Pharmacotherapeutic properties and emerging potential clinical applications

Hu, R. W., Carey, E. J., Lindor, K. & Tabibian, J. H., Nov 1 2017, In : Annals of Hepatology. 16, 6, p. 835-841 7 p.

Research output: Contribution to journalArticle

Curcumin
Curcuma
Sclerosing Cholangitis
Rhizome
Cholangiocarcinoma
5 Citations (Scopus)

Emerging treatments for primary sclerosing cholangitis

Rodriguez, E. A., Carey, E. J. & Lindor, K., May 4 2017, In : Expert Review of Gastroenterology and Hepatology. 11, 5, p. 451-459 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
End Stage Liver Disease
Cholangiocarcinoma
Inflammatory Bowel Diseases
2 Citations (Scopus)

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters

Martin, P. & Lindor, K., Sep 30 2017, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Liver Transplantation
3 Citations (Scopus)

Investigational drugs in phase II clinical trials for primary biliary cholangitis

Silveira, M. G. & Lindor, K., Oct 3 2017, In : Expert Opinion on Investigational Drugs. 26, 10, p. 1115-1121 7 p.

Research output: Contribution to journalReview article

Investigational Drugs
Phase II Clinical Trials
Cholangitis
Ursodeoxycholic Acid
Fibrosis
2 Citations (Scopus)

Joint society statement for elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Jan 1 2017, In : Annals of Hepatology. 16, 1, p. 6-7 2 p.

Research output: Contribution to journalEditorial

Hepatitis, Viral, Human
Preventive Health Services
Predictive Value of Tests
Medical Societies
Hepatitis
16 Citations (Scopus)

Old and new treatments for primary biliary cholangitis

Chascsa, D., Carey, E. J. & Lindor, K., Apr 1 2017, In : Liver International. 37, 4, p. 490-499 10 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Histology
Chenodeoxycholic Acid
100 Citations (Scopus)

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

on behalf of the & International PSC Study Group, Jun 1 2017, In : Gastroenterology. 152, 8, p. 1975-1984.e8

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Phenotype
Liver Transplantation
Neoplasms
2016
11 Citations (Scopus)

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Steatorrhea
Ursodeoxycholic Acid
Cholangiocarcinoma
21 Citations (Scopus)

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Biomarkers
Survival
Liver Transplantation
289 Citations (Scopus)

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

Cholangitis
Placebos
Ursodeoxycholic Acid
Bilirubin
Alkaline Phosphatase
10 Citations (Scopus)

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Fluorescence In Situ Hybridization
Cholangiocarcinoma
Liver Transplantation
Cholangiography
10 Citations (Scopus)

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jul 14 2016, (Accepted/In press) In : Journal of Clinical Gastroenterology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Tretinoin
Bile Acids and Salts
Alanine Transaminase
5 Citations (Scopus)

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

Immunoglobulins
10 Citations (Scopus)

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

Cholangitis
Pharmaceutical Preparations
Ursodeoxycholic Acid
Therapeutics
HLA Antigens
4 Citations (Scopus)

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

Hepatitis
Joints
1 Citation (Scopus)

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

Hepatitis
Joints
8 Citations (Scopus)

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Antibodies
Control Groups
Bilirubin
Alkaline Phosphatase
1 Citation (Scopus)

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis